Home -> Law Blog Directory -> Patent Law Blogs -> Patently Obvious
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patently ObviousTiming of the Notice of Allowance, Issue Fee Payment, and Patent Issuance
By Dennis Crouch
A Patently-O reader asked a question about the timing of a patent's issuance and whether the date of issue-fee payment affects the issue date. i.e., whether 'the patent will issue on the same day regardless of whether the issue fee is paid immediately after receiving the notice of allowance or waiting until the statutory deadline to pay. Any thoughts?'
To answer this question, I pulled-up the file histories for 630 patents issued on June 8, 2010 and created a table comparing the respective dates of (1) the notice of allowance, (2) payment of the issue fee, and (3) issuance of the patent. I limited the sample to include only payments made within the statutory three-month window. Some file histories included multiple notices of allowance. For those, I only looked at the last-mailed notice.
Answer: As the charts shows below, the timing of issuance is closely correlated with timing of the payment of the issue fee. In my sample, 88% of the patents issued within 6–8 weeks of payment of the issue fee. Those that took longer were, for the most part, associated with older applications. In addition, the delay was greater for applicants that waited until the deadline to pay the issue fee.

The second chart shows a histogram of delay from the payment of the issue fee until patent issuance. Most patents issue in the sixth-week after payment.

The final chart shows patent applicant delay in payment of the issue fee. The chart was created by comparing the date of issue fee payment to the three-month payment deadline. More than 50% of applicants waited until the the week of the deadline to pay their issue fee. Why the delay?

Full post as published by Patently Obvious on June 09, 2010 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
AireSurf Networks Holdings Inc.
$23,147 debt settlement made by issuance of 115,735 common shares.
Mr. Brown Instant Coffee
Possible Melamine Contamination Prompts Canadian Agency to Issue Warning
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
UnitedHealth
Settles Payment Suits for $350 Million

Patent Profile: Vermillion Announces Allowance of Ovarian Cancer Biomarker Application
Notice of Allowance on trademark "cloud computing" revoked
Why are patent allowance rates declining
Patent Profile: Neuralstem Announces Allowance of Neural Stem Cell Application







